NIH's Role In Sustaining the U.S. Economy 2021 Update Now Available here
UMR Urges House and Senate Leaders to Include NIH Funding in COVID Relief Package read here
UMR releases new fact sheets on COVID-19 and biomedical research. Read here
See how UMR members are aiding in the fight against the coronavirus here
A new episode of the Amazing Things Podcast is now available! Check it out here.

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Pausing AstraZeneca vaccinations in Europe a ‘tragic’ decision

Many European nations—including France, Germany, Italy, Portugal, and Spain—recently paused the use of AstraZeneca’s vaccine due to alleged adverse reactions. The nations said they were waiting for the European Medicines Agency to declare the vaccine safe, which it did on March 18. But the decision to pause the vaccine’s use over concerns about rare blood clots may severely damage the continent’s vaccination efforts moving forward, just as the continent is experiencing a new surge in COVID-19 cases, says Bill Moss, executive director of the Johns Hopkins International Vaccine Access Center. Pausing was a “tragic” decision that likely strengthened existing vaccine distrust that will be even harder to diminish, he says.